Condition Overview

COPD

For people managing chronic obstructive pulmonary disease under a physician's care.

Cellular artwork for COPD Personalized review, grounded in your health history.

Understanding COPD

Chronic obstructive pulmonary disease, or COPD, is a long-term lung disease that limits airflow and can make breathing difficult. It includes emphysema and chronic bronchitis. Diagnosis and management belong with a pulmonologist or primary care clinician and may involve prescribed medication, pulmonary rehabilitation, vaccination, smoking cessation support, and oxygen when medically indicated.

Cellular and regenerative approaches are being researched, but they are not established treatment for COPD. The FDA specifically warns that regenerative medicine products promoted for pulmonary disease may be unapproved and may expose patients to risk. Nothing discussed here replaces inhalers, rehabilitation, oxygen, or urgent evaluation when breathing worsens.

Our consultation reviews your diagnosis, current respiratory care, recent stability, and goals. A licensed provider explains the limits of the evidence and decides whether any supportive assessment is appropriate. Many people will not be eligible. If you still smoke, stopping remains the single change with the largest effect on how COPD progresses, and a provider will raise it.

If your breathing suddenly worsens, your lips or fingertips turn blue, you cannot finish a sentence, or you become confused or unusually drowsy, call 911 or go to the nearest emergency department. Do not wait for a consultation. If your breathing difficulty began after a COVID infection, our Long COVID Supportive Care page covers overlapping ground, and other pulmonary diagnoses are covered on Lung Diseases.

Potential Benefits

A COPD consultation may help you:

  • A structured review of your COPD history, your prescribed respiratory care, and your recent stability
  • A plain account of why no regenerative product is FDA approved for COPD and what the research has not shown
  • Screening for factors that affect eligibility, including recent exacerbations, oxygen use, and smoking status
  • Questions to discuss with your pulmonologist or primary care clinician
  • A practical next step if a licensed provider recommends further assessment

Who May Benefit

A COPD assessment may make sense for people including:

  • People with a confirmed COPD diagnosis who remain under pulmonary care
  • Individuals whose breathing has been clinically stable and who want to discuss research questions
  • People preparing questions for a pulmonologist or primary care visit
  • Adults who understand that established COPD care must continue
  • People able to complete a medical screening and share a current medication list

Therapies a Provider May Consider

Every option is reviewed individually after your history, current care, and goals are understood.

What the Research Looks At

COPD has established diagnostic and management pathways. Research on cellular and regenerative approaches remains experimental, and no exosome product is FDA approved for COPD. These references provide condition guidance, regulatory context, and registered-study information.

  1. COPD National Heart, Lung, and Blood Institute, NIH
  2. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes U.S. Food and Drug Administration
  3. Registered clinical trials related to COPD ClinicalTrials.gov, U.S. National Library of Medicine

Start With an Assessment

Every visit begins with a consultation and a medical screening. A licensed provider decides what, if anything, is appropriate for you.

Terms you may hear when discussing COPD

Pulmonary care has its own vocabulary, and knowing a few of these terms makes both your specialist visits and a consultation here more useful.

  • Spirometry and FEV1. Spirometry is the breathing test used to diagnose COPD and grade how limited airflow is. FEV1 is the amount of air you can force out in the first second, and it is the number your pulmonologist tracks over time.
  • Exacerbation. A flare-up in which breathlessness, cough or sputum worsen beyond the usual day-to-day variation, often triggered by infection and often needing extra treatment. A recent exacerbation is one of the reasons a provider here will say no for now.
  • Pulmonary rehabilitation. A supervised program of exercise, breathing techniques and education for people with chronic lung disease. It is part of established COPD care, not something a consultation replaces.
  • Supplemental oxygen. Oxygen prescribed when blood oxygen levels are low. Whether you use it, and how much, is part of the screening review.

A licensed provider reviews your diagnosis, current respiratory care and recent stability before deciding whether anything here is appropriate to consider alongside your pulmonologist’s plan. Nothing offered is a treatment for COPD.

Related conditions in this care area: Lung Diseases. If your breathing difficulty began after a COVID infection, see Long COVID Supportive Care. Back to Respiratory Support.

COPD

Frequently Asked Questions

No. Nothing offered here is a cure or an approved treatment for COPD. The purpose of the consultation is to review your history, explain the limits of current research, and decide whether any supportive assessment is appropriate.
No. We do not take over diagnosis, disease management, rehabilitation, or prescribed medication. Anything discussed here sits alongside the care provided by your existing clinical team.
COPD is one of the most heavily advertised conditions in that market, and the FDA has published a consumer alert about regenerative medicine products promoted for conditions including lung disease. Ask any clinic which registered study its protocol sits under and who reviews it. A price quoted before any assessment is a warning sign on its own.
Unstable breathing, a recent exacerbation, oxygen dependence, or COPD that is not currently managed by a pulmonologist or primary care clinician. In this care area the answer is no more often than yes, and being told that no further step is appropriate is a normal outcome of an honest assessment.
Hitech Regen serves Southern California. Availability and suitability are discussed during the consultation before any visit is scheduled.
Cost is discussed after a licensed provider determines whether anything is appropriate to consider. We do not quote a condition-specific plan before the assessment.
Yes. Inhaled therapy in COPD is prescribed and adjusted by your pulmonologist or primary care physician. We do not change prescribed medication, and nothing discussed here is a reason to stop or reduce an inhaler.
We make no claim of that kind. Nothing offered here is a cure and no product we work with is FDA approved for COPD.
Not automatically, but say so at intake. It is part of the medical screening, and the provider will want your pulmonary records before discussing any next step.
Yes. Pulmonary rehabilitation is part of established COPD care and nothing here replaces it. Do not drop or reschedule it around a consultation with us.
Book a Consultation